2016 Hematological Malignancies

First page Previous page 1777 Next page Last page

Further therapy needed?

A. No (just observation) B. Brentuximab Vedotin C. Anti-PD1

0%

0% 0% 0%

Enter answer text...

Enter answer text...

Enter answer text...

Enter answer text...

Made with